Subsequent Events (Details Narrative) - USD ($)					1 Months Ended	12 Months Ended
	Feb. 04, 2016	Feb. 02, 2016	Feb. 02, 2016	Jan. 06, 2016	Mar. 03, 2016	Dec. 31, 2014	Jan. 29, 2016
Sold units for aggregate cash consideration						$ 928,500
Subsequent Event [Member]
Number of common stock shares					4,266,683
Warrant to purchase common stock during period					8,533,366
Received subscriptions					$ 94,635
Subsequent Event [Member] | Chief Scientific Officer [Member]
Issued a demand promissory note principal amount							$ 52,600
Subsequent Event [Member] | Dr. Lippa [Member]
Warrant to purchase common stock during period		3,350,319
Warrants exercisable price per share		$ 0.0157	$ 0.0157
Convertible debt							$ 52,600
Subsequent Event [Member] | Dr. Manuso [Member]
Warrant to purchase common stock during period	2,630,000
Warrants exercisable price per share	$ 0.02
Additional loan payable			$ 52,600
Debt instruments interest rate		10.00%	10.00%
Subsequent Event [Member] | Purchase Agreement [Member]
Sold units for aggregate cash consideration				$ 100,000
Number of common stock shares				4,508,567
Warrant to purchase common stock during period				9,017,133
Maximum proceeds from private placements				$ 2,500,000
Per unit price of private placement				$ 0.02218
Warrants exercisable price per share				$ 0.0244
Warrants expire date				Feb. 28, 2021
Percentage of beneficially own upon conversion				4.99%